Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Ipratropium bromide: Began Phase I/II study

Sheffield Pharmaceuticals Inc. (SHM), St. Louis, Mo.

Read the full 71 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE